PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 162 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $20,000 | -9.1% | 1,890 | +11.6% | 0.00% | 0.0% |
| Q2 2019 | $22,000 | -66.7% | 1,694 | -0.6% | 0.00% | -86.7% |
| Q1 2019 | $66,000 | +106.2% | 1,705 | +8.6% | 0.02% | +87.5% |
| Q4 2018 | $32,000 | -51.5% | 1,570 | +8.3% | 0.01% | -38.5% |
| Q3 2018 | $66,000 | -16.5% | 1,450 | +8.6% | 0.01% | -18.8% |
| Q2 2018 | $79,000 | -86.9% | 1,335 | -47.5% | 0.02% | -68.0% |
| Q1 2015 | $601,000 | +67.9% | 2,544 | +34.7% | 0.05% | +66.7% |
| Q4 2014 | $358,000 | -12.5% | 1,888 | +10.0% | 0.03% | -9.1% |
| Q3 2014 | $409,000 | +101.5% | 1,717 | -44.3% | 0.03% | +106.2% |
| Q2 2014 | $203,000 | -73.8% | 3,082 | -58.5% | 0.02% | -71.4% |
| Q1 2014 | $774,000 | +46.6% | 7,427 | +45.6% | 0.06% | +36.6% |
| Q4 2013 | $528,000 | – | 5,100 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |